Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Latent Labs, the company building AI foundation models to make biology programmable, today emerged from stealth with $50M in total funding to accelerate their progress and partnerships.

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics and machine learning company Zymergen (bought by Ginkgo Bioworks in 2022), ...

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

National Human Rights Commission wrote to YouTube seeking removal of the videos featuring Ranveer Allahbadia. Interestingly, ...

A new wave of controversy dominated the Indian media's attention after Podcaster Ranveer Allahbadia made a distasteful ...

Your brain constantly juggles sensory information to make split-second decisions, but how? A new latent circuit model ...